Showing results (1-10 of 353) with videos related to
Sort By:
Pageof 36
Clinical and Experimental Immunology|February 1, 1997
Tumour cell killing using chemically engineered antibody constructs specific for tumour cells and the complement inhibitor CD59C L Harris, K S Kan, G T Stevenson, et al.Immunology|October 1, 1995
Characterization of a glycosyl-phosphatidylinositol anchor-deficient subline of Raji cells. An analysis of the functional importance of complement inhibitors on the Raji cell lineC L Harris, B P MorganCell Biophysics|June 1, 1995
Linkage of silver to antibodies through 2-imino thiolaneD K Hazra, G T Stevenson, K S KanJournal of Immunological Methods|June 5, 1999
Efficient generation of monoclonal antibodies against surface-expressed proteins by hyperexpression in rodent cellsO B Spiller, C L Harris, B P MorganJournal of Immunology (Baltimore, Md. : 1950)|March 1, 1997
Conjugation of human Fc gamma in closed-hinge or open-hinge configuration to Fab'gamma and analogous ligandsG T Stevenson, V A Anderson, K S Kan, et al.Biochemical Society Transactions|November 21, 2002
Tailoring anti-complement therapeuticsC L Harris, D A Fraser, B P MorganThe Biochemical Journal|July 27, 1999
Molecular and functional analysis of mouse decay accelerating factor (CD55)C L Harris, N K Rushmere, B P MorganImmunology|August 6, 2000
Human and rodent decay-accelerating factors (CD55) are not species restricted in their complement-inhibiting activitiesC L Harris, O B Spiller, B P MorganClinical and Experimental Immunology|August 8, 2002
Coupling complement regulators to immunoglobulin domains generates effective anti-complement reagents with extended half-life in vivoC L Harris, A S Williams, S M Linton, et al.Clinical Nephrology|November 13, 2008
Complement, roles in renal disease and modulation for therapyN J Hepburn, M M Ruseva, C L Harris, et al.Pageof 36